Harish Seethapathy

Dr. Floege presenting on IgA from his car in a snowstorm!

So amazed, our @glomcon.org fellows are very grateful, can't thank him enough 😊

MGHkidneys not here yet but delighted to welcome our next class of fellows!

A familiar last name on the list…

ODS has other risk factors that may be more important than correction.

Calling ODS a purely iatrogenic disease is preposterous in many cases. Blameful on docs, rates can’t always be controlled exactly. Litigation :(

Flaws of studies that guidelines are based on >> flaws of recent studies.

This data will be criticized like recent studies. But:

Not all slow correction is because of underlying disease. Hesitancy in correction/relowering are issues = increased LOS.

ODS: ill-defined, extremely rare, questionable relationship to rates (in an era where no one corrects >15)